Rex American [REX] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Rex American
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Rex American wins in 11 metrics, Asp Isotopes wins in 7 metrics, with 0 ties. Rex American appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rex American | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.82 | -14.84 | Asp Isotopes |
| Price-to-Book Ratio | 1.67 | 17.12 | Rex American |
| Debt-to-Equity Ratio | 4.23 | 84.08 | Rex American |
| PEG Ratio | 23.93 | -67.33 | Asp Isotopes |
| EV/EBITDA | 8.67 | -26.59 | Asp Isotopes |
| Profit Margin (TTM) | 8.86% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 5.30% | -721.89% | Rex American |
| EBITDA Margin (TTM) | 5.30% | N/A | N/A |
| Return on Equity | 11.48% | -115.46% | Rex American |
| Return on Assets (TTM) | 5.90% | -26.14% | Rex American |
| Free Cash Flow (TTM) | $-7.13M | $-28.07M | Rex American |
| 1-Year Return | 14.22% | 335.65% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 1.40 | 217.23 | Rex American |
| Enterprise Value | $688.31M | $743.82M | Asp Isotopes |
| EV/Revenue Ratio | 1.08 | 168.84 | Rex American |
| Gross Profit Margin (TTM) | 9.06% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $37 | $0 | Rex American |
| Earnings per Share (Diluted) | $3.23 | $-0.57 | Rex American |
| Beta (Stock Volatility) | 0.56 | 3.38 | Rex American |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rex American vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rex American | -1.66% | -3.21% | 9.69% | 34.52% | 26.13% | 25.10% |
| Asp Isotopes | 0.64% | -5.90% | 27.85% | 78.22% | 53.51% | 90.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rex American | 14.22% | 71.20% | 135.69% | 226.39% | 943.55% | 994.88% |
| Asp Isotopes | 335.65% | 236.07% | 236.07% | 236.07% | 236.07% | 236.07% |
Performance & Financial Health Analysis: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $894.76M | $957.01M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 88,450 | 6,359,020 |
| 90 Day Avg. Volume | 121,570 | 4,387,103 |
| Last Close | $53.43 | $9.41 |
| 52 Week Range | $33.45 - $55.36 | $1.86 - $10.82 |
| % from 52W High | -3.49% | -13.03% |
| All-Time High | $60.79 (Apr 01, 2024) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -12.11% | -13.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.31% |
| Quarterly Earnings Growth | -0.15% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.39% |
| Operating Margin (TTM) | 0.05% | -7.22% |
| Return on Equity (TTM) | 0.11% | -1.15% |
| Debt to Equity (MRQ) | 4.23 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $32.56 | $0.59 |
| Cash per Share (MRQ) | $19.18 | $0.75 |
| Operating Cash Flow (TTM) | $62.98M | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $-25,565,124 | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.82 | -14.84 |
| Forward P/E | 23.93 | -67.33 |
| PEG Ratio | 23.93 | -67.33 |
| Price to Sales (TTM) | 1.40 | 217.23 |
| Price to Book (MRQ) | 1.67 | 17.12 |
| Market Capitalization | ||
| Market Capitalization | $894.76M | $957.01M |
| Enterprise Value | $688.31M | $743.82M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.08 | 168.84 |
| Enterprise to EBITDA | 8.67 | -26.59 |
| Risk & Other Metrics | ||
| Beta | 0.56 | 3.38 |
| Book Value per Share (MRQ) | $32.56 | $0.59 |
Financial Statements Comparison: Rex American vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Revenue/Sales | $158.34M | $1.10M |
| Cost of Goods Sold | $144.00M | $774,765 |
| Gross Profit | $14.34M | $326,840 |
| Research & Development | N/A | $1.53M |
| Operating Income (EBIT) | $8.40M | $-7.95M |
| EBITDA | $13.42M | $-8.23M |
| Pre-Tax Income | $13.63M | $-8.53M |
| Income Tax | $2.95M | $-70,720 |
| Net Income (Profit) | $10.67M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Cash & Equivalents | $159.91M | $55.97M |
| Total Current Assets | $398.77M | $59.03M |
| Total Current Liabilities | $42.58M | $8.18M |
| Long-Term Debt | $19.04M | $36.96M |
| Total Shareholders Equity | $619.64M | $45.73M |
| Retained Earnings | $768.61M | $-64.62M |
| Property, Plant & Equipment | $0 | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | REX | ASPI |
|---|---|---|
| Operating Cash Flow | $-2.75M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-10.38M | $-5.53M |
| Debt Repayment | N/A | $-262,304 |
| Common Stock Repurchase | $-32.67M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | REX | ASPI |
|---|---|---|
| Shares Short | 462,118 | 16.34M |
| Short Ratio | 3.35 | 4.67 |
| Short % of Float | 0.04% | 0.24% |
| Average Daily Volume (10 Day) | 88,450 | 6,359,020 |
| Average Daily Volume (90 Day) | 121,570 | 4,387,103 |
| Shares Outstanding | 17.19M | 72.07M |
| Float Shares | 14.45M | 54.53M |
| % Held by Insiders | 0.14% | 0.23% |
| % Held by Institutions | 0.88% | 0.37% |
Dividend Analysis & Yield Comparison: Rex American vs Asp Isotopes
| Metric | REX | ASPI |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |